Health and environment

New Tech Could Transform the $60B Marijuana Industry

FN Media Group Presents OilPrice.com News Commentary  The back pain was killing him – clearly, the time had come to seek treatment. But instead of prescription drugs, Todd Guillion opted for medical marijuana. Why not? The Orange County, California native figured it had to be safer than pharmaceuticals. But shortly after beginning his cannabis regimen, he began suffering terrible numbness in his arms, hands and feet. Mentioned in today”s commentary

A Darker Side to Diabetes: 51% of Patients Have Been Treated for Stress or Mental Health Issues, According to New Survey by Ieso

Ahead of UK Mental Health Awareness Week 2018 (14th to 21st May), an independent survey of people diagnosed with type 1 and 2 diabetes, commissioned by Ieso Digital Health highlights the scale of stress and mental health problems affecting those living with this chronic condition.  Three quarters (75%) of young adults (16-34) believe that their mental health has been negatively affected by their diabetes    Almost half (46%) say that

The Vital Healthtech Solution the Cannabis Industry Can't Live Without

MarketNewsUpdates.com News Commentary   As the recreational floodgates open soon nationally in Canada and state by state in the US there is one main concern, quality. Companies in the space providing different cannabis services, from growing to logistics include Canopy Growth (TSX: WEED) (OTC:TWMJF), Hydropothecary (TSX-V: THCX), Maricann Group Inc. (CSE: MARI) (OTC:MRRCF), Tyler Technologies and HealthSpace Data Systems Ltd. (CSE: HS) (OTC: HDSLF) (FRA:38H). Although, as noted mid-February, the

BenevolentAI Acquires Advanced Cambridge Research Facility to Accelerate Its AI-enabled Drug Development

Acquisition creates first AI company capable of covering entire drug development process from drug discovery to clinical development  Cambridge research facility will advance BenevolentAI drug programmes into the clinic more quickly and at a much larger scale  BenevolentAI, one of the world”s largest private AI companies, today announced that it has acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge (UK) for an undisclosed